SIA
BIO icon

SkyView Investment Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

SkyView Investment Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$540K Sell
1,936
-12
-0.6% -$3.46K 0.07% 185
2025
Q4 		$590K Sell
1,948
-51
-3% -$15.9K 0.07% 186
2025
Q3 		$561K Sell
1,999
-23
-1% -$6.26K 0.07% 189
2025
Q2 		$493K Sell
2,022
-8
-0.4% -$1.89K 0.07% 202
2025
Q1 		$494K Buy
2,030
+172
+9% +$51.7K 0.07% 200
2024
Q4 		$610K Buy
+1,858
New +$631K 0.1% 178
2023
Q3 		– Sell
-2
Closed -$1K – 612
2023
Q2 		$1K Buy
2
+1
+100% +$407 ﹤0.01% 632
2023
Q1 		$0 Buy
+1
New +$468 ﹤0.01% 666
2022
Q1 		– Sell
-2,267
Closed -$3K – 586
2021
Q4 		$3K Buy
+2,267
New +$1.7M ﹤0.01% 551

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return